InsiderSource
ROIV

Roivant Sciences Ltd.

SEC CIK 1635088
$30.04 +38.8% · 90 days
90-day buys
$0
0 open-market
90-day sells
$28.38M
6 open-market
Net insider flow
−$28.38M
Net selling
Filings shown
54
Most recent
Advertisement

At a glance

Over the last 90 days, insiders at ROIV have sold a net $28.38M of stock (0 open-market buys vs 6 sells).

Largest recent trade: Torti Frank sold $38.39M of ROIV, trimming their stake 9%.

Most active filer: Venker Eric, with 10 transactions among the recent filings shown.

Insider transaction history

Form 4 filings for ROIV, newest first
View on SEC EDGAR ↗
ROIV
Roivant Sciences Ltd.
Sell Venker Eric · President & Immunovant CEO · Open-market sale · filed 3w ago ΔOwn −11%

Venker Eric sold $6.05M of ROIV, trimming their stake 11%.

−$6.05M
200,000 sh @ $30
ROIV
Roivant Sciences Ltd.
Tax withholding Venker Eric · President & Immunovant CEO · Tax withholding · filed 3w ago ΔOwn −2.1%
−$1.12M
34,483 sh @ $32
ROIV
Roivant Sciences Ltd.
Option exercise Venker Eric · President & Immunovant CEO · Option exercise · filed Apr 22, 2026 ΔOwn +12%
+$770K
200,000 sh @ $4
Advertisement
ROIV
Roivant Sciences Ltd.
Sell Venker Eric · President & Immunovant CEO · Open-market sale · filed Apr 22, 2026 ΔOwn −11%

Venker Eric sold $5.92M of ROIV, trimming their stake 11%.

−$5.92M
200,000 sh @ $30
ROIV
Roivant Sciences Ltd.
Sell Gline Matthew · Director, CEO · Open-market sale · filed Apr 20, 2026 ΔOwn −1.7%

Gline Matthew sold $8.45M of ROIV, trimming their stake 2%.

−$8.45M
289,774 sh @ $29
ROIV
Roivant Sciences Ltd.
Sell Humes Jennifer · Chief Accounting Officer · Open-market sale · filed Apr 10, 2026 ΔOwn −14%

Humes Jennifer sold $384.1K of ROIV, trimming their stake 14%.

−$384.1K
13,538 sh @ $28
ROIV
Roivant Sciences Ltd.
Tax withholding Torti Frank · President and Vant Chair · Tax withholding · filed Apr 2, 2026 ΔOwn −1.2%
−$4.43M
160,035 sh @ $28
ROIV
Roivant Sciences Ltd.
Sell Fitzgerald Meghan · Director · Open-market sale · filed Mar 30, 2026 ΔOwn −62%

Fitzgerald Meghan sold $1.92M of ROIV, trimming their stake 62%.

−$1.92M
70,000 sh @ $27
ROIV
Roivant Sciences Ltd.
Option exercise Venker Eric · President & Immunovant CEO · Option exercise · filed Mar 19, 2026 ΔOwn +12%
+$770K
200,000 sh @ $4
ROIV
Roivant Sciences Ltd.
Sell Venker Eric · President & Immunovant CEO · Open-market sale · filed Mar 19, 2026 ΔOwn −11%

Venker Eric sold $5.65M of ROIV, trimming their stake 11%.

−$5.65M
200,000 sh @ $28
ROIV
Roivant Sciences Ltd.
Sell Epperly Melissa B, · Director · Open-market sale · filed Mar 18, 2026 ΔOwn −73%

Epperly Melissa B, sold $1.2M of ROIV, trimming their stake 73%.

−$1.2M
41,861 sh @ $29
ROIV
Roivant Sciences Ltd.
Option exercise Torti Frank · President and Vant Chair · Option exercise · filed Feb 23, 2026 ΔOwn +4.3%
+$2.26M
587,390 sh @ $4
Advertisement

About ROIV insider activity

This page tracks every recent Form 4 filed for Roivant Sciences Ltd. with the U.S. Securities and Exchange Commission. Form 4 is the disclosure that company insiders — officers, directors, and holders of more than 10% of the stock — must file within two business days of buying or selling shares.

The summary above nets open-market purchases against open-market sales over the trailing 90 days. Open-market trades (codes P and S) tend to carry the most signal because they reflect a deliberate choice to put money in or take it out, as opposed to routine grants, option exercises, or tax-withholding events. Use the badges on each row to tell them apart, and always confirm details against the original filing before drawing conclusions.

Frequently asked questions

How often is ROIV insider data updated?

Continuously. We read from SEC EDGAR, so new Form 4 filings for Roivant Sciences Ltd. usually appear here within minutes of being accepted by the SEC.

What does "net insider flow" mean?

It is the total dollar value of open-market insider purchases minus open-market sales over the last 90 days. A positive number (green) means insiders bought more than they sold; a negative number (red) means the reverse.

Why do some rows show grants or option exercises instead of buys?

Insiders receive stock through compensation as well as buying it outright. Form 4 captures all of these. We label each transaction by its SEC code so you can focus on open-market activity if you prefer.

Is this investment advice?

No. InsiderSource presents public filing data for informational purposes only. Insider activity is one of many factors to consider and is never a recommendation to buy or sell.